Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2007; 49:1763-1769, doi:10.1016/j.jacc.2006.11.052 (Published online 13 April 2007).
© 2007 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Study Group and Centers
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (45)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Poldermans, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Poldermans, D.
Related Collections
Right arrowRelated Article

A Clinical Randomized Trial to Evaluate the Safety of a Noninvasive Approach in High-Risk Patients Undergoing Major Vascular Surgery

The DECREASE-V Pilot Study

Don Poldermans, MD*,*, Olaf Schouten, MD{dagger}, Radosav Vidakovic, MD{ddagger}, Jeroen J. Bax, MD§, Ian R. Thomson, MD||, Sanne E. Hoeks, MSc{ddagger}, Harm H.H. Feringa, MD{ddagger}, Martin Dunkelgrün, MD{dagger}, Peter de Jaegere, MD{ddagger}, Alexander Maat, MD, Marc R.H.M. van Sambeek, MD{dagger}, Miklos D. Kertai, MD*, Eric Boersma, PhD{ddagger} for the DECREASE Study Group

* Department of Anesthesiology, Erasmus Medical Center, Rotterdam, the Netherlands
{dagger} Department of Vascular Surgery, Erasmus Medical Center, Rotterdam, the Netherlands
{ddagger} Department of Cardiology, Erasmus Medical Center, Rotterdam, the Netherlands
Department of Cardiothoracic Surgery, Erasmus Medical Center, Rotterdam, the Netherlands
§ Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
|| Department of Anesthesiology, University of Alberta, Winnipeg, Manitoba, Canada.


Figure 1
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Flowchart of the Study

Cardiac risk factors included age over 70 years, angina pectoris, prior myocardial infarction (MI) on the basis of history or a finding of pathologic Q waves on electrocardiography, compensated congestive heart failure or a history of congestive heart failure, current treatment for diabetes mellitus, renal dysfunction (serum creatinine >160 µmol/l), and prior stroke or transient ischemic attack. Patients with >3 risk factors and extensive ischemia were randomly (1:1) assigned to coronary revascularization.

 

Figure 2
View larger version (5K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 Incidence of All-Cause Death or Myocardial Infarction During 1-Year Follow-Up According to the Allocated Strategy in Patients With 3 or More Cardiac Risk Factors With Extensive Stress-Induced Ischemia

Light line = best medical treatment only; dark line = best medical treatment and prophylactic revascularization.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement